Upgrade to SI Premium - Free Trial

Ligand Pharma (LGND) Tops Q2 EPS by 13c

July 30, 2019 8:04 AM
Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $0.68 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings

Next Articles